Roche Wants New Ruling On Tarceva
Swiss drug maker Roche has asked European health authorities to reexamine the data regarding its pancreatic cancer medicine, Tarceva, in light of a recent negative ruling....To view the full article, register now.
Already a subscriber? Click here to view full article